The massive potential dilution (up to 4.8M shares vs. 5.4M outstanding) and the company's precarious financial position (going concern, Nasdaq non-compliance) create a highly unfavorable risk/reward. Monitor for Nasdaq's determination on compliance and any subsequent warrant exercises that would further pressure the stock. The stock is likely to face persistent selling pressure from the resale registration.
Executive Summary
Amesite Inc. filed an S-1 registration statement for the resale of up to 4,836,245 shares of common stock by selling stockholders, primarily related to warrants issued in an April 2026 private placement. The company, which pivoted to AI-powered healthcare solutions for the post-acute care market, has a history of losses, substantial doubt about its ability to continue as a going concern, and faces Nasdaq delisting risk. The company will not receive proceeds from the resale but could receive up to ~$5.38 million if all warrants are exercised for cash.
Key Facts
- Selling stockholders are offering up to 4,836,245 shares of common stock on a resale basis.
- Shares consist of 418,118 shares issued, plus shares issuable upon exercise of pre-funded warrants, Series A-1 warrants, Series A-2 warrants, and placement agent warrants.
- Company will not receive proceeds from the resale; potential gross proceeds of ~$5.38 million if all warrants are exercised for cash.
- Net losses of approximately $3,617,000 (FY2025) and $4,403,000 (FY2024).
- Substantial doubt about ability to continue as a going concern.
- Received Nasdaq deficiency letter on October 28, 2025 for non-compliance with minimum stockholders' equity requirement; granted extension until April 27, 2026.
- Stock price on May 1, 2026 was $1.05 per share; market cap ~$4M.
- CEO Ann Marie Sastry and director George Parmer are among selling stockholders, offering 522,648 and 731,706 shares respectively.
Financial Impact
Potential gross proceeds of ~$5.38 million if all warrants exercised; net losses of ~$3.6M (FY2025) and ~$4.4M (FY2024).
Risk Factors
- Massive dilution: up to 4.8M additional shares could be sold, nearly doubling the current share count.
- Going concern risk: company has substantial doubt about its ability to continue operations.
- Nasdaq delisting risk: non-compliance with minimum stockholders' equity requirement.
- Insider selling: CEO and a director are among the selling stockholders.
- History of losses with no clear path to profitability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001213900-26-055211 |
| Document: ea028973301ex5-1.htm | 0001213900-26-055211 |
| Document: ea028973301ex-fee.htm | 0001213900-26-055211 |
| Document: ea028973301ex23-2.htm | 0001213900-26-055211 |
| Document: ea028973301ex23-1.htm | 0001213900-26-055211 |
| Document: 0001213900-26-055211-index-headers.html | 0001213900-26-055211 |
| Document: 0001213900-26-055211-index.html | 0001213900-26-055211 |
| Document: 0001213900-26-055211.txt | 0001213900-26-055211 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | DEFA14A | $0.8825 | awaiting T+60 | — | $0.5926 (−32.85%) |
Oct 14, 2026 12d ago | DEF 14A | $0.8825 | awaiting T+60 | — | $0.5926 (−32.85%) |
Jun 3, 2026 20w ago | DEFA14A | $1.39 $1.06 | ▼ −23.74% | ▼ −25.62% | $0.5926 (−57.37%) |
May 29, 2026 21w ago | EFFECT | $1.41 $1.16 | ▲ +17.73% | ▲ +18.91% | $0.5926 (+57.97%) |
May 19, 2026 23w ago | 8-K | $1.73 $1.07 | ▼ −38.15% | ▼ −44.44% | $0.5926 (−65.75%) |
May 12, 2026 23w ago | S-1 | $0.8310 $1.05 | ▼ −26.35% | ▼ −21.92% | $0.5926 (+28.69%) |
Apr 28, 2026 26w ago | 424B5 | $0.9800 $0.9519 | ▲ +2.87% | ▲ +6.86% | $0.5926 (+39.53%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▲ +6.65% | ▲ +11.42% | $0.5926 (+43.56%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▼ −6.65% | ▼ −11.42% | $0.5926 (−43.56%) |
Apr 20, 2026 27w ago | S-1 | $1.30 $1.05 | ▲ +19.23% | ▲ +26.13% | $0.5926 (+54.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers